polyvidone iodine eye drops 1%
polyvidone 10mg/ml
prep solution- povidone-iodine solution
dukal corporation - povidone-iodine, 10% (equivalent to 1% available iodine) - antiseptic healthcare antiseptic for preparation of the skin prior to surgery - first aid antiseptic to help prevent infection in minor cuts, scrapes and burns
hypotears plus
adcock ingram limited - polyvidone - solution - each 1 ml solution contains polyvidone 50 mg
hypotears plus sdu
adcock ingram limited - polyvidone - solution - each 1 ml solution contains polyvidone 50 mg (no preservative)
oculotect 50/mg/ml mg/ml eye drops solution
novartis pharmaceuticals uk ltd - polyvidone 25 - eye drops solution - 50/mg/ml mg/ml
oculotect 50mg/ml mg/ml eye drops solution
novartis pharmaceuticals uk ltd - polyvidone 25 - eye drops solution - 50mg/ml mg/ml
oculotect eye drops solution 50/mg/ml mg/ml
novartis pharmaceuticals uk ltd - polyvidone 25 - eye drops solution - 50/mg/ml mg/ml
oculotect eye drops solution 50mg/ml mg/ml
novartis pharmaceuticals uk ltd - polyvidone 25 - eye drops solution - 50mg/ml mg/ml
primolut-nor
bayer israel ltd - norethisterone acetate - tablets - norethisterone acetate 5 mg - norethisterone - norethisterone - oral progestron for: dysfunctional bleeding, primary and secondary amenorrhea, premenstrual syndrome, timing of mensturation and endometriosis.
citalopram- citalopram tablet
preferred pharmaceuticals inc. - citalopram hydrobromide (unii: i1e9d14f36) (citalopram - unii:0dhu5b8d6v) - citalopram 10 mg - citalopram tablets are indicated for the treatment of depression. the efficacy of citalopram tablets in the treatment of depression was established in 4 to 6 week, controlled trials of outpatients whose diagnosis corresponded most closely to the dsm-iii and dsm-iii-r category of major depressive disorder (see clinical pharmacology ). a major depressive episode (dsm-iv) implies a prominent and relatively persistent (nearly every day for at least 2 weeks) depressed or dysphoric mood that usually interferes with daily functioning, and includes at least five of the following nine symptoms: depressed mood, loss of interest in usual activities, significant change in weight and/or appetite, insomnia or hypersomnia, psychomotor agitation or retardation, increased fatigue, feelings of guilt or worthlessness, slowed thinking or impaired concentration, a suicide attempt or suicidal ideation. the antidepressant action of citalopram tablets in hospitalized depressed patients has not been adequately studied. the efficacy o